- Filed
- Dec 23, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Dec 13, 2024 | 251.23M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 250M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 262M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $28M |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $1.23B |
| Capex | Q1 2024 · Mar 31, 2024 | $71M |
| Capex | Q1 2024 · Mar 31, 2023 | $76M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $1.84B |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $1.79B |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $14B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $11.69B |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $10.13B |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | $14.67B |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | $14.24B |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $13.6B |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $13.9B |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $138.04B |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $137.48B |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $152.71B |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $151.71B |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | $3.25 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | $3.50 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | $3.25 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $3.50 |
| Net Income restated | Q1 2024 · Mar 31, 2024 | $851M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | $955M |